The Food and Drug Administration is important because it is the federal agency that decides whether the drugs, vaccines, medical devices, and most of the foods you buy are safe enough to reach you, and it can force dangerous ones off the market once they’re out there. When the FDA works, most people never think about it, which is the point. The stakes show up in what’s absent from store shelves: prescriptions that failed their trials, contaminated produce that was pulled before it spread, defective devices that never made it to a hospital.
The agency sits inside the Department of Health and Human Services, and its reach covers prescription medications, vaccines, the bulk of the U.S. food supply, dietary supplements, cosmetics, tobacco products, and electronic devices that emit radiation.1Food and Drug Administration. About FDA What that reach means in practice is worth walking through category by category, because the level of protection you actually get is different for each one.
What the FDA Reviews Before Products Reach You
No new prescription drug can legally be sold in the United States until the FDA reviews a New Drug Application and determines the medication’s benefits outweigh its risks. The application must include full reports from clinical investigations showing the drug is both safe and effective for its intended use.2Office of the Law Revision Counsel. 21 U.S. Code 355 – New Drugs A manufacturer typically spends years running trials on thousands of patients before it can even file. The FDA then conducts its own independent analysis of that data rather than taking the company’s word for it, and applications can be denied if trials were poorly designed, the data is incomplete, or the labeling is misleading.
Generics take a shorter path. A generic manufacturer files an Abbreviated New Drug Application demonstrating that its product is bioequivalent to the brand-name version, meaning it delivers the same amount of active ingredient into the bloodstream in the same timeframe.3Food and Drug Administration. Abbreviated New Drug Application (ANDA) That’s why generics cost a fraction of brand-name prices: the underlying safety and effectiveness research was already done once.
Vaccines and Other Biologics
Vaccines, blood components, and gene therapies face their own approval standard. No biological product can enter interstate commerce without a biologics license, and the FDA will only grant that license after the manufacturer demonstrates the product is safe, pure, and potent.4Office of the Law Revision Counsel. 42 USC 262 – Regulation of Biological Products Potent is the key word. It means the product reliably produces the intended effect at the labeled strength, which matters enormously for a vaccine that depends on triggering a specific immune response. The FDA also inspects the facilities where biologics are manufactured, because even a well-designed vaccine can become dangerous if contamination enters the production line.
Medical Devices
The FDA sorts medical devices into three tiers based on patient risk, and the regulatory burden scales with the tier:
- Class I covers low-risk products like bandages and tongue depressors. Most are exempt from premarket review but still must follow basic manufacturing standards.
- Class II covers moderate-risk devices such as infusion pumps and powered wheelchairs, which must meet specific performance standards before marketing.
- Class III covers high-risk devices like pacemakers and replacement heart valves, which require a full premarket approval application demonstrating safety and effectiveness, similar in rigor to a new drug application.5Food and Drug Administration. Classify Your Medical Device
Software is increasingly part of this picture. The FDA regulates software that functions as a medical device on its own, for example an app that analyzes medical images to flag potential tumors.6Food and Drug Administration. Software as a Medical Device (SaMD) As care moves further into digital tools, this category keeps growing.
How the FDA Protects the Food Supply
The FDA oversees the majority of the U.S. food supply, including produce, seafood, dairy, packaged goods, and most beverages. Meat and poultry fall primarily under the Department of Agriculture instead. The Food Safety Modernization Act shifted the FDA’s approach from reacting to outbreaks toward preventing them.7Food and Drug Administration. Food Safety Modernization Act (FSMA) Food facilities must develop written safety plans that identify potential hazards, including pathogens, allergens, and chemical residues, and spell out the specific preventive controls they’ll use for each.8Food and Drug Administration. FSMA Final Rule for Preventive Controls for Human Food
Labels function as a safety tool, not just marketing. Federal law requires packaged foods to identify the presence of any major food allergen. As of January 2023, there are nine: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame.9Food and Drug Administration. Addition to the 2022 Food Code – Sesame Added as a Major Food Allergen The allergen’s food source must appear either in the ingredient list or in a separate “Contains” statement.10Food and Drug Administration. Food Allergies For the roughly two percent of adults and five percent of young children with food allergies, that label can be the difference between a safe meal and an emergency room visit. Standardized nutrition labeling — calories, fats, vitamins — comes from the same authority. A product with missing or deceptive labeling is considered misbranded under federal law.
Imports don’t escape this. U.S.-based importers bear direct responsibility for verifying that their foreign suppliers meet American food safety standards. Under the Foreign Supplier Verification Program, each importer must conduct a written hazard analysis for every food it brings in, evaluate and formally approve its foreign suppliers, and carry out ongoing verification activities like audits or testing. If an importer discovers a supplier isn’t meeting the required standards, it must take corrective action, which can mean cutting the supplier off entirely.11eCFR. Foreign Supplier Verification Programs for Food Importers
Where FDA Oversight Is Lighter Than People Assume
Not everything on the shelf goes through the same review, and this catches consumers out. Dietary supplements are the clearest example. Under the Dietary Supplement Health and Education Act of 1994, manufacturers are responsible for evaluating the safety and labeling of their own products before selling them. The FDA does not review or approve supplements before they hit store shelves the way it does with prescription drugs.12Food and Drug Administration. Dietary Supplements The agency can act against products that turn out to be adulterated or mislabeled, but only after the product is already on the market.
That’s why supplement bottles carry a legally required disclaimer in bold: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”13Food and Drug Administration. Letter to the Dietary Supplement Industry on the DSHEA Disclaimer It means what it says.
Cosmetics historically received lighter oversight than nearly any other FDA-regulated product: no premarket approval, no mandatory facility registration. The Modernization of Cosmetics Regulation Act of 2022 changed that. Manufacturers and processors must now register their facilities with the FDA and renew every two years, and companies must report serious adverse events within 15 business days.14Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022 (MoCRA) Even so, the FDA still does not approve individual cosmetic products before sale. It can act against products with harmful ingredients or misleading labels only after they reach consumers.
Tobacco sits under FDA authority too. The Family Smoking Prevention and Tobacco Control Act let the agency restrict sales to minors, require health warnings on packaging, and set product standards, including limits on nicotine levels or flavors designed to attract younger users.15Office of the Law Revision Counsel. Public Law 111-31 – Family Smoking Prevention and Tobacco Control Act In 2016 that authority was extended to cover e-cigarettes, cigars, pipe tobacco, and hookah products that had operated outside federal regulation.16Federal Register. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act
What Happens After a Product Is on the Market
Approval is the beginning, not the end. Once products reach consumers, the FDA tracks safety signals through MedWatch, which collects adverse event reports from health care professionals, patients, and consumers. The system covers prescription and over-the-counter drugs, biologics, medical devices, and cosmetics.17Food and Drug Administration. MedWatch – FDA Safety Information and Adverse Event Reporting Program These reports let the agency spot problems that clinical trials, which involve thousands of people at most, can’t catch in a population of millions. The FDA also inspects manufacturing facilities to verify ongoing compliance and issues warning letters when a facility falls short.
Recalls
When a product turns out to be unsafe, the FDA coordinates recalls. Most are technically voluntary — the company agrees to pull its product — but the agency classifies each recall by severity so the public understands the risk:
- Class I: a reasonable probability that the product will cause serious harm or death.
- Class II: the product may cause temporary or reversible health problems, or the chance of serious harm is remote.
- Class III: the product is unlikely to cause any health consequences.18Food and Drug Administration. Recalls Background and Definitions
For food, the FDA can go beyond voluntary cooperation and order a mandatory recall when there’s a reasonable probability that a food is adulterated or mislabeled in a way that will cause serious harm or death. The agency must first give the company an opportunity to recall voluntarily; the mandatory order kicks in only when the company refuses or fails to act.19Food and Drug Administration. Annual Report on the Use of Mandatory Recall Authority FY 2022
Penalties
Criminal penalties for violating the Federal Food, Drug, and Cosmetic Act include fines up to $1,000 and up to one year in prison for a first offense. A violation committed with intent to defraud or mislead, or a repeat offense after a prior conviction, can bring up to three years in prison and fines up to $10,000.20Office of the Law Revision Counsel. 21 USC 333 – Penalties On the civil side, the government can go to federal court to seize adulterated or misbranded products wherever they’re found in interstate commerce.21Office of the Law Revision Counsel. 21 U.S. Code 334 – Seizure The agency can also seek injunctions to shut down a manufacturing line or block a company from shipping. These aren’t hypothetical powers; the FDA uses them regularly against companies that ignore warning letters or keep selling dangerous products.
Emergency Use When Normal Timelines Are Too Slow
When a public health emergency strikes — a pandemic, a bioterror attack, a chemical or radiological threat — the normal approval timeline may be too slow. The FDA can issue an Emergency Use Authorization to allow unapproved medical products to be used before the full approval process is complete. This requires a formal emergency declaration and a finding by the FDA that, based on the totality of available scientific evidence, it’s reasonable to believe the product may be effective and that its known and potential benefits outweigh its known and potential risks.22Office of the Law Revision Counsel. 21 USC 360bbb-3 – Authorization for Medical Products for Use in Emergencies
An EUA is not full approval. The evidence standard is deliberately lower — “may be effective” rather than the proven effectiveness required for a standard application — and an EUA expires when the underlying emergency declaration ends. The COVID-19 pandemic made this pathway familiar, but the legal framework has existed since 2004 and covers any qualifying threat. It’s a large part of why the FDA matters when a fast response is the only response that will help.